Related Experiment Video

Updated: Aug 17, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries

B Karadag1, F Karakoc, R Ersu

  • 1Division of Pediatric Pulmonology, Marmara University, Istanbul, Turkey. bkaradag@hotmail.com

Respiration; International Review of Thoracic Diseases
|June 9, 2005
PubMed

Insights

Childhood non-cystic-fibrosis bronchiectasis is a significant pediatric morbidity in developing nations. Appropriate treatment, including surgery in select cases, can lead to clinical improvement and reduced respiratory infections.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Global Health

Background:

  • Childhood non-cystic-fibrosis bronchiectasis is a prevalent cause of childhood morbidity, particularly in developing countries.
  • Management of pediatric non-cystic-fibrosis bronchiectasis presents challenges, with limited data on long-term outcomes.
  • Understanding the characteristics and causative factors is crucial for effective pediatric respiratory care.

Purpose of the Study:

  • To define the general characteristics of children diagnosed with non-cystic-fibrosis bronchiectasis.
  • To identify underlying causative factors contributing to non-cystic-fibrosis bronchiectasis in pediatric patients.
  • To evaluate the long-term follow-up results and clinical outcomes of non-cystic-fibrosis bronchiectasis management.

Main Methods:

  • Retrospective analysis of 111 consecutive children diagnosed with non-cystic-fibrosis bronchiectasis.
  • Data collection included general characteristics, underlying causes, and medical records.
  • Clinical outcomes assessed via lung function tests, annual exacerbation rates, and patient/parent-reported health status.

Main Results:

  • An underlying etiology was identified in 62.2% of patients, with post-infectious bronchiectasis being the most common cause (29.7%).
  • Despite intensive medical treatment, 23.4% of patients required surgical intervention.
  • Significant improvements observed in annual lower respiratory infection rates (p < 0.0001) and lung function (FEV1% p=0.01, FVC% p=0.04) during follow-up.

Conclusions:

  • Non-cystic-fibrosis bronchiectasis remains a significant pediatric concern, especially in developing countries.
  • Infections are key etiological factors, and appropriate treatment, including surgery for selected cases, can achieve clinical improvement.
  • While medical management is primary, surgical consideration is vital for specific pediatric bronchiectasis patients.
Abstract

More Related Videos

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.